← Eichor
Study identifier: NCT06882733 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Immediate Effect of Applying Transcutaneous Electrical Nerve Stimulation (TENS) on Sympathetic Ganglion and Gastrocnemius for Popliteal Blood Flow

Condition: Transcutaneous Electrical Nerve Stimulation (TENS) · Popliteal · Blood Flow  ·  Sponsor: Kaohsiung Medical University

PhaseNA
Planned participants43
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This study aims to evaluate the immediate hemodynamic effects of transcutaneous electrical nerve stimulation (TENS) on the popliteal artery and vein. Vascular issues like PAOD and DVT are common in patients with diabetes, obesity, or immobility due to increased resistance and reduced blood flow. Traditional treatments (medication or surgery) are not always feasible, prompting interest in TENS as an alternative. Although primarily used for pain relief, TENS may enhance blood flow. This research compares different stimulation frequencies (80 Hz vs. 4 Hz) and sites (gastrocnemius muscle vs. thoracolumbar sympathetic ganglia) to identify the most effective configuration.

This description comes directly from the study's public registry record.

Talk to the study team

Mengjie Shen  ·  +886935751158  ·  mengjie910419@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kaohsiung Medical UniversityKaohsiung City, Taiwan, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06882733